Cogentis Therapeutics cogentistherapeutics.com


Public list: Pharma Startups (6570) Neuroscience Startups (947)

Cogentis Therapeutics is developing a drug to treat a family of neurodegenerative disorders, including Alzheimer's Disease, Pick's Disease, and our initial target condition, Frontotemporal Degeneration, also known as Frontotemporal Dementia (FTD). The company's drug can cross into the brain and prevent the process which leads to neural decay, dementia, and cell death.

Cogentis Therapeutics is developing a drug to treat a family of neurodegenerative disorders, including Alzheimer's Disease, Pick's Disease, and our initial target condition, Frontotemporal Degeneration, also known as Frontotemporal Dementia (FTD). Th...Show all

Company (Alive / Active)

Phone: 443-842-6856

Fax:

3717 Boston Street
#138
Baltimore, 21224
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cogentis Therapeutics $0M May 21, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cogentis Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
MassChallengeIncubator/AcceleratorBoston, Massachusetts, United StatesIncubator/Accelerator
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)